Cytogenetic methods in human biomonitoring: Principles and uses

Methods in Molecular Biology

Volumn 817, Issue , 2012, Pages 305-334

  Mateuca, Raluca A ^a   Decordier, Ilse ^a   Kirsch Volders, Micheline ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Cellular phenotypes; Chromosomal aberrations; Cytokinesis block micronucleus assay; High frequency cells; Micronuclei; Sister chromatid exchanges

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; HUMAN; METHODOLOGY; MICRONUCLEUS; MICRONUCLEUS TEST; PHENOTYPE; SISTER CHROMATID EXCHANGE;

CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; HUMANS; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; PHENOTYPE; SISTER CHROMATID EXCHANGE;

EID: 84855991272     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-421-6_15     Document Type: Article

References (133)

1. Salama SA, Serrana M and Au WW (1999). Biomonitoring using accessible human cells for exposure and health risk assessment. Mutat Res 436(1):99-112. (Pubitemid 29044048)
2. Au WW (2007). Usefulness of biomarkers in population studies: from exposure to susceptibility and to prediction of cancer. Int J Hyg Environ Health 210(3-4):239-46. (Pubitemid 46618099)
3. Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, Merlo F, Natarajan AT, Norppa H, Shuker DE, Tice R and others (2000). IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. International Programme on Chemical Safety. Mutat Res 463(2):111-72. (Pubitemid 30460066)
4. Helleday T, Nilsson R and Jenssen D (2000). ArsenicIII and heavy metal ions induce intrachromosomal homologous recombination in the hprt gene of V79 Chinese hamster cells. Environ Mol Mutagen 35(2):114-22. (Pubitemid 30171820)
5. Garcia-Sagredo JM (2008). Fifty years of cytogenetics: A parallel view of the evolution of cytogenetics and genotoxicology. Biochim Biophys Acta 1779(6-7):363-75. (Pubitemid 351847867)
6. Wilson DM, 3rd and Thompson LH (2007). Molecular mechanisms of sister-chromatid exchange. Mutat Res 616(1-2):11-23. (Pubitemid 46198860)
7. Helleday T (2003). Pathways for mitotic homologous recombination in mammalian cells. Mutat Res 532(1-2):103-15. (Pubitemid 37487849)
8. Dean BJ and Danford, N (1984). Assays for the detection of chemically-induced chromosome damage in cultured mammalian cells. In: S. Venitt, Parry JM, editors. Mutagenicity Testing-a Practical Approach. Oxford: IRL Press. p 187-232.
9. Carrano A and Moore D (1982). The Rationale and Methodology for quantifying Sister Chromatid Exchange in Humans. In: Heddle JA, editor. Mutagenicity: New Horizons in Genetic Toxicology. New York: Academic Press Inc. p 267-304.
10. Hagmar L, Brogger A, Hansteen IL, Heim S, Hogstedt B, Knudsen L, Lambert B, Linnainmaa K, Mitelman F, Nordenson I and others (1994). Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res 54(11):2919-22. (Pubitemid 24187773)
11. Hagmar L, Bonassi S, Stromberg U, Brogger A, Knudsen LE, Norppa H and Reuterwall C (1998). Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res 58(18):4117-21. (Pubitemid 28440567)
12. Bonassi S, Lando C, Ceppi M, Landi S, Rossi AM and Barale R (2004). No association between increased levels of high-frequency sister chromatid exchange cells (HFCs) and the risk of cancer in healthy individuals. Environ Mol Mutagen 43(2):134-6. (Pubitemid 38332729)
13. Norppa H, Bonassi S, Hansteen IL, Hagmar L, Stromberg U, Rossner P, Boffetta P, Lindholm C, Gundy S, Lazutka J and others (2006). Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat Res 600(1-2):37-45.
14. Moore D and Carrano A (1984). Statistical Analysis of High SCE Frequency. In: Tice R, Hollaender A, editors. Sister Chromatid Exchanges. New York and London Plenum Press. p 469-479.
15. Marez T, Shirali P, Hildebrand HF and Haguenoer JM (1991). Increased frequency of sister chromatid exchange in workers exposed to high doses of methylmethacrylate. Mutagenesis 6(2):127-9.
16. Motykiewicz G, Michalska J, Pendzich J, Perera FP and Chorazy M (1992). A cytoge-netic study of men environmentally and occu-pationally exposed to airborne pollutants. Mutat Res 280(4):253-9.
17. Van Hummelen P, Gennart JP, Buchet JP, Lauwerys R and Kirsch-Volders M (1993). Biological markers in PAH exposed workers and controls. Mutat Res 300(3-4):231-9. (Pubitemid 23210092)
18. Yager JW (1987). Effect of concentration-time parameters on sister-chromatid exchanges induced in rabbit lymphocytes by ethylene oxide inhalation. Mutat Res 182(6):343-52. (Pubitemid 17166432)
19. Kelsey KT, Wiencke JK, Eisen EA, Lynch DW, Lewis TR and, Little JB (1988). Persistently elevated sister chromatid exchanges in ethylene oxide-exposed primates: the role of a subpopulation of high frequency cells. Cancer Res 48(17):5045-50.
20. Kelsey KT, Wiencke JK, Eisen EA, Lynch DW, Lewis TR and Little JB (1989). Sister chromatid exchange in chronic ethylene oxide-exposed primates: unexpected effects of in vitro culture duration, incubation temperature, and serum supplementation. Cancer Res 49(7):1727-31. (Pubitemid 19108395)
21. Ponzanelli I, Landi S, Bernacchi F and Barale R (1997). The nature of high frequency sister chromatid exchange cells (HFCs). Mutagenesis 12(5):329-33. (Pubitemid 27417570)
22. Bolognesi C, Abbondandolo A, Barale R, Casalone R, Dalpra L, De Ferrari M, Degrassi F, Forni A, Lamberti L, Lando C and others (1997). Age-related increase of baseline frequencies of sister chromatid exchanges, chromosome aberrations, and micronuclei in human lymphocytes. Cancer Epidemiol Biomarkers Prev 6(4):249-56. (Pubitemid 27172890)
23. Bender MA, Preston RJ, Leonard RC, Pyatt BE, Gooch PC and Shelby MD (1988). Chromosomal aberration and sister-chromatid exchange frequencies in peripheral blood lymphocytes of a large human population sample. Mutat Res 204(3):421-33. (Pubitemid 18072335)
24. Bukvic N, Gentile M, Susca F, Fanelli M, Serio G, Buonadonna L, Capurso A and Guanti G (2001). Sex chromosome loss, micronuclei, sister chromatid exchange and aging: a study including 16 centenarians. Mutat Res 498(1-2):159-67. (Pubitemid 32973671)
25. Tuimala J, Szekely G, Wikman H, Jarventaus H, Hirvonen A, Gundy S and Norppa H (2004). Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: effects on levels of sister chromatid exchanges and chromosomal aberrations. Mutat Res 554(1-2):319-33. (Pubitemid 39140839)
26. Zijno A, Andreoli C, Leopardi P, Marcon F, Rossi S, Caiola S, Verdina A, Galati R, Cafolla A and Crebelli R (2003). Folate status, metabolic genotype, and biomarkers of genotoxic-ity in healthy subjects. Carcinogenesis 24(6):1097-103. (Pubitemid 36827262)
27. Wong RH, Wang JD, Hsieh LL and Cheng TJ (2003). XRCC1, CYP2E1 and ALDH2 genetic polymorphisms and sister chromatid exchange frequency alterations amongst vinyl chloride monomer-exposed polyvinyl chloride workers. Arch Toxicol 77(8):433-40.
28. Perez-Cadahia B, Lafuente A, Cabaleiro T, Pasaro E, Mendez J and Laffon B (2007). Initial study on the effects of Prestige oil on human health. Environ Int 33(2):176-85. (Pubitemid 44960465)
29. Sram RJ, Rossner P, Peltonen K, Podrazilova K, Mrackova G, Demopoulos NA, Stephanou G, Vlachodimitropoulos D, Darroudi F and Tates AD (1998). Chromosomal aberrations, sister-chromatid exchanges, cells with high frequency of SCE, micronuclei and comet assay parameters in 1, 3-butadiene-exposed workers. Mutat Res 419(1-3):145-54. (Pubitemid 28512980)
30. Lei YC, Hwang SJ, Chang CC, Kuo HW, Luo JC, Chang MJ and Cheng TJ (2002). Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers. Mutat Res 519(1-2):93-101. (Pubitemid 34874990)
31. Laczmanska I, Gil J, Karpinski P, Stembalska A, Kozlowska J, Busza H, Trusewicz A, Pesz K, Ramsey D, Schlade-Bartusiak K and others (2006). Influence of polymorphisms in xeno-biotic-metabolizing genes and DNA-repair genes on diepoxybutane-induced SCE frequency. Environ Mol Mutagen 47(9):666-73. (Pubitemid 44917678)
32. Mateuca RA, Carton C, Roesems S, Roelants M, Lison D and Kirsch-Volders M. (2010) Genotoxicity surveillance program in workers dismantling arsenic trichloride-containing ammunition. Int Arch Occup Environ Health 83: 483-495.
33. Schroder KR, Wiebel FA, Reich S, Dannappel D, Bolt HM and Hallier E (1995). Glutathione-S-transferase (GST) theta polymorphism influences background SCE rate. Arch Toxicol 69(7):505-7.
34. Wiencke JK, Pemble S, Ketterer B and Kelsey KT (1995). Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev 4(3):253-9.
35. Norppa H, Bemardini S, Wikman H, Jarventaus H, Rosenberg C, Bolognesi C and Hirvonen A (2000). Cytogenetic biomarkers in occupational exposure to diisocyanates: influence of genetic polymorphisms of metabolic enzymes. Environ Mol Mutagen 35(Suppl. 31):45.
36. Laffon B, Pasaro E and Mendez J (2002). Evaluation of genotoxic effects in a group of workers exposed to low levels of styrene. Toxicology 171(2-3):175-86. (Pubitemid 34142491)
37. van Poppel G, de Vogel N, van Balderen PJ and Kok FJ (1992). Increased cytogenetic damage in smokers deficient in glutathione S-transferase isozyme mu. Carcinogenesis 13(2):303-5.
38. Cheng TJ, Christiani DC, Wiencke JK, Wain JC, Xu X and Kelsey KT (1995). Comparison of sister chromatid exchange frequency in peripheral lymphocytes in lung cancer cases and controls. Mutat Res 348(2):75-82.
39. Duell EJ, Wiencke JK, Cheng TJ, Varkonyi A, Zuo ZF, Ashok TD, Mark EJ, Wain JC, Christiani DC and Kelsey KT (2000). Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 21(5):965-71. (Pubitemid 30265141)
40. Carere A, Andreoli C, Galati R, Leopardi P, Marcon F, Rosati MV, Rossi S, Tomei F, Verdina A, Zijno A and others (2002). Biomonitoring of exposure to urban air pollutants: analysis of sister chromatid exchanges and DNA lesions in peripheral lymphocytes of traffic policemen. Mutat Res 518(2):215-24. (Pubitemid 46135383)
41. Mateuca R, Lombaert N, Aka PV, Decordier I and Kirsch-Volders M (2006). Chromosomal changes: induction, detection methods and applicability in human biomonitoring. Biochimie 88(11):1515-31. (Pubitemid 44762225)
42. Russell PJ (2002). Chromosomal mutations. In: Cummings B, editor. Genetics. San Francisco: Pearson Education Inc. p 595-621.
43. Hagmar L, Stromberg U, Bonassi S, Hansteen IL, Knudsen LE, Lindholm C and Norppa H (2004). Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts. Cancer Res 64(6):2258-63. (Pubitemid 38339481)
44. Schwartz JL and Jordan R (1997). Selective elimination of human lymphoid cells with unstable chromosome aberrations by p53-dependent apoptosis. Carcinogenesis 18(1):201-5. (Pubitemid 28134634)
45. Mateuca R and Kirsch-Volders, M (2007). Chromosomal damage. In: P.B. Farmer, S.A. Kyrtopoulos, Emmeny JM, editors. State of validation of biomarkers of carcinogen exposure and early effects and their applicability to molecular epidemiology. Lodz, Poland: Nofer Institute of Occupational medicine. p 24-32.
46. Carbonell E, Peris F, Xamena N, Creus A and Marcos R (1996). Chromosomal aberration analysis in 85 control individuals. Mutat Res 370(1):29-37. (Pubitemid 26300945)
47. Ramsey MJ, Moore DH, 2nd, Briner JF, Lee DA, Olsen L, Senft JR and Tucker JD (1995). The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosome painting. Mutat Res 338(1-6):95-106.
48. Pressl S, Edwards A and Stephan G (1999). The influence of age, sex and smoking habits on the background level of fish-detected translocations. Mutat Res 442(2):89-95. (Pubitemid 29313429)
49. Tawn EJ and Whitehouse CA (2001). Frequencies of chromosome aberrations in a control population determined by G banding. Mutat Res 490(2):171-7. (Pubitemid 32126684)
50. Whitehouse CA, Edwards AA, Tawn EJ, Stephan G, Oestreicher U, Moquet JE, Lloyd DC, Roy L, Voisin P, Lindholm C and others (2005). Translocation yields in peripheral blood lymphocytes from control populations. Int J Radiat Biol 81(2):139-45. (Pubitemid 40839857)
51. Stephan G and Pressl S (1999). Chromosomal aberrations in peripheral lymphocytes from healthy subjects as detected in first cell division. Mutat Res 446(2):231-7.
52. Sidneva ES, Katosova LD, Platonova VI, Beketova NA, Kodentsova VM, Chebotarev AN, Durnev AD and Bochkov NP (2005). Effects of vitamin supply on spontaneous and chemically induced mutagenesis in human cells. Bull Exp Biol Med 139(2):230-4. (Pubitemid 41357412)
53. Dusinska M, Kazimirova A, Barancokova M, Beno M, Smolkova B, Horska A, Raslova K, Wsolova L and Collins AR (2003). Nutritional supplementation with antioxidants decreases chromosomal damage in humans. Mutagenesis 18(4):371-6. (Pubitemid 36850205)
54. Volkovova K, Barancokova M, Kazimirova A, Collins A, Raslova K, Smolkova B, Horska A, Wsolova L and Dusinska M (2005). Antioxidant supplementation reduces inter-individual variation in markers of oxidative damage. Free Radic Res 39(6):659-66. (Pubitemid 40846838)
55. Catalan J, Heilimo I, Falck GC, Jarventaus H, Rosenstrom P, Nykyri E, Kallas-Tarpila T, Pitkamaki L, Hirvonen A and Norppa H (2009). Chromosomal aberrations in railroad transit workers: Effect of genetic polymorphisms. Environ Mol Mutagen. 50: 304-316.
56. van Diemen PC, Maasdam D, Vermeulen S, Darroudi F and Natarajan AT (1995). Influence of smoking habits on the frequencies of structural and numerical chromosomal aberrations in human peripheral blood lymphocytes using the fluorescence in situ hybridization (FISH) technique. Mutagenesis 10(6):487-95.
57. Landi S, Norppa H, Frenzilli G, Cipollini G, Ponzanelli I, Barale R and Hirvonen A (1998). Individual sensitivity to cytogenetic effects of 1, 2:3, 4-diepoxybutane in cultured human lymphocytes: influence of glutathione S-transferase M1, P1 and T1 genotypes. Pharmacogenetics 8(6):461-71. (Pubitemid 29043378)
58. Sorsa M, Osterman-Golkar S, Peltonen K, Saarikoski ST and Sram R (1996). Assessment of exposure to butadiene in the process industry. Toxicology 113(1-3):77-83. (Pubitemid 26364077)
59. Sram RJ, Beskid O, Binkova B, Chvatalova I, Lnenickova Z, Milcova A, Solansky I, Tulupova E, Bavorova H, Ocadlikova D and others (2007). Chromosomal aberrations in environmentally exposed population in relation to metabolic and DNA repair genes polymorphisms. Mutat Res 620(1-2):22-33. (Pubitemid 46776721)
60. Migliore L, Naccarati A, Coppede F, Bergamaschi E, De Palma G, Voho A, Manini P, Jarventaus H, Mutti A, Norppa H and others (2006). Cytogenetic biomarkers, urinary metabolites and metabolic gene polymorphisms in workers exposed to styrene. Pharmacogenet Genomics 16(2):87-99. (Pubitemid 43145677)
61. Vodicka P, Soucek P, Tates AD, Dusinska M, Sarmanova J, Zamecnikova M, Vodickova L, Koskinen M, de Zwart FA, Natarajan AT and others (2001). Association between genetic polymorphisms and biomarkers in styrene-exposed workers. Mutat Res 482(1-2):89-103. (Pubitemid 32787086)
62. Vodicka P, Kumar R, Soucek P, Haufroid V, Stetina R, Dusinska M, Kuricova M, Zamecnikova M, Buchanova J, Norppa H and others (2003). Genetic polymorphisms of DNA repair and biotransformation genes and possible links with chromosomal aberrations and single-strand breaks in DNA. Toxicol Lett 144(Suppl. 1):s154.
63. Pluth JM, Ramsey MJ and Tucker JD (2000). Role of maternal exposures and newborn genotypes on newborn chromosome aberration frequencies. Mutat Res 465(1-2):101-11. (Pubitemid 30119924)
64. Knudsen LE, Norppa H, Gamborg MO, Nielsen PS, Okkels H, Soll-Johanning H, Raffn E, Jarventaus H and Autrup H (1999). Chromosomal aberrations in humans induced by urban air pollution: influence of DNA repair and polymorphisms of glutathione S-transferase M1 and N-acetyltransferase 2. Cancer Epidemiol Biomarkers Prev 8(4 Pt 1):303-10. (Pubitemid 29193901)
65. Norppa H, Lindholm C, Ojajarvi A, Salomaa S and Hirvonen A (2001). Metabolic polymorphisms and frequency of chromosomal aberrations. Environ Mol Mutagen 37(Suppl. 32):58.
66. Affatato AA, Wolfe KJ, Lopez MS, Hallberg C, Ammenheuser MM and Abdel-Rahman SZ (2004). Effect of XPD/ERCC2 polymorphisms on chromosome aberration frequencies in smokers and on sensitivity to the mutagenic tobacco-specific nitrosamine NNK. Environ Mol Mutagen 44(1):65-73. (Pubitemid 38982073)
67. Vodicka P, Kumar R, Stetina R, Sanyal S, Soucek P, Haufroid V, Dusinska M, Kuricova M, Zamecnikova M, Musak L and others (2004). Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis 25(5):757-63. (Pubitemid 38618528)
68. Bonassi S and Au WW (2002). Biomarkers in molecular epidemiology studies for health risk prediction. Mutat Res 511(1):73-86. (Pubitemid 34241514)
69. Bonassi S, Abbondandolo A, Camurri L, Dal Pra L, De Ferrari M, Degrassi F, Forni A, Lamberti L, Lando C, Padovani P and others (1995). Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet Cytogenet 79(2):133-5.
70. Hagmar L, Bonassi S, Stromberg U, Mikoczy Z, Lando C, Hansteen IL, Montagud AH, Knudsen L, Norppa H, Reuterwall C and others (1998). Cancer predictive value of cytogenetic markers used in occupational health surveillance programs. Recent Results Cancer Res 154:177-84.
71. Hagmar L, Bonassi S, Stromberg U, Mikoczy Z, Lando C, Hansteen IL, Montagud AH, Knudsen L, Norppa H, Reuterwall C and others (1998). Cancer predictive value of cytogenetic markers used in occupational health surveillance programs: a report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health. Mutat Res 405(2):171-8. (Pubitemid 29042193)
72. Bonassi S, Hagmar L, Stromberg U, Montagud AH, Tinnerberg H, Forni A, Heikkila P, Wanders S, Wilhardt P, Hansteen IL and others (2000). Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res 60(6):1619-25. (Pubitemid 30183433)
73. Liou SH, Lung JC, Chen YH, Yang T, Hsieh LL, Chen CJ and Wu TN (1999). Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area. Cancer Res 59(7):1481-4. (Pubitemid 29160114)
74. Rossner P, Boffetta P, Ceppi M, Bonassi S, Smerhovsky Z, Landa K, Juzova D and Sram RJ (2005). Chromosomal aberrations in lymphocytes of healthy subjects and risk of cancer. Environ Health Perspect 113(5):517-20. (Pubitemid 40711337)
75. Boffetta P, van der Hel O, Norppa H, Fabianova E, Fucic A, Gundy S, Lazutka J
76. Cebulska-Wasilewska A, Puskailerova D, Znaor A and others (2007). Chromosomal aberrations and cancer risk: results of a cohort study from Central Europe. Am J Epidemiol 165(1):36-43. (Pubitemid 46026207)
77. Bonassi S, Norppa H, Ceppi M, Stromberg U, Vermeulen R, Znaor A, Cebulska-Wasilewska A, Fabianova E, Fucic A, Gundy S and others (2008). Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22 358 subjects in 11 countries. Carcinogenesis 29(6):1178-83. (Pubitemid 351958697)
78. Fenech M and Morley AA (1985). Measurement of micronuclei in lymphocytes. Mutat Res 147(1-2):29-36. (Pubitemid 15111220)
79. Thomas P, Umegaki K and Fenech M (2003). Nucleoplasmic bridges are a sensitive measure of chromosome rearrangement in the cytokinesis-block micronucleus assay. Mutagenesis 18(2):187-94. (Pubitemid 36336536)
80. Fenech M (2005). The Genome Health Clinic and Genome Health Nutrigenomics concepts: diagnosis and nutritional treatment of genome and epigenome damage on an individual basis. Mutagenesis 20(4):255-69. (Pubitemid 41399465)
81. Fenech M, Baghurst P, Luderer W, Turner J, Record S, Ceppi M and Bonassi S (2005). Low intake of calcium, folate, nicotinic acid, vitamin E, retinol, beta-carotene and high intake of pantothenic acid, biotin and ribofla-vin are significantly associated with increased genome instability-results from a dietary intake and micronucleus index survey in South Australia. Carcinogenesis 26(5): 991-9. (Pubitemid 41214329)
82. Fenech M (2002). Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discov Today 7(22):1128-37. (Pubitemid 35346420)
83. Decordier I, Dillen L, Cundari E and Kirsch-Volders M (2002). Elimination of micronu-cleated cells by apoptosis after treatment with inhibitors of microtubules. Mutagenesis 17(4):337-44. (Pubitemid 34814656)
84. Leach NT and Jackson-Cook C (2004). Micronuclei with multiple copies of the X chromosome: do chromosomes replicate in micronuclei? Mutat Res 554(1-2):89-94. (Pubitemid 39140817)
85. Van Hummelen P and Kirsch-Volders M (1990). An improved method for the 'in vitro' micronucleus test using human lymphocytes. Mutagenesis 5(2):203-4. (Pubitemid 20274560)
86. Kirsch-Volders M, Vanhauwaert A, De Boeck M and Decordier I (2002). Importance of detecting numerical versus structural chromosome aberrations. Mutat Res 504(1-2):137-48. (Pubitemid 34775107)
87. Kirsch-Volders M and Fenech M (2001). Inclusion of micronuclei in non-divided mononuclear lymphocytes and necrosis/apoptosis may provide a more comprehensive cytokinesis block micronucleus assay for biomonitoring purposes. Mutagenesis 16(1):51-8. (Pubitemid 32049213)
88. Fenech M, Holland N, Chang WP, Zeiger E and Bonassi S (1999). The HUman MicroNucleus Project-An international collaborative study on the use of the micronu-cleus technique for measuring DNA damage in humans. Mutat Res 428(1-2):271-83. (Pubitemid 29389698)
89. Fenech M (2000). The in vitro micronucleus technique. Mutat Res 455(1-2):81-95.
90. Norppa H and Falck GC (2003). What do human micronuclei contain? Mutagenesis 18(3):221-33. (Pubitemid 36592414)
91. Kimura M, Umegaki K, Higuchi M, Thomas P and Fenech M (2004). Methylenetetrahydrofolate reductase C677T polymorphism, folic acid and riboflavin are important determinants of genome stability in cultured human lymphocytes. J Nutr 134(1):48-56. (Pubitemid 38057422)
92. Kirsch-Volders M, Elhajouji A, Cundari E and Van Hummelen P (1997). The in vitro micro-nucleus test: a multi-endpoint assay to detect simultaneously mitotic delay, apoptosis, chromosome breakage, chromosome loss and non-disjunction. Mutat Res 392(1-2): 19-30. (Pubitemid 27327005)
93. Fenech M (2006). Cytokinesis-block micro-nucleus assay evolves into a "cytome" assay of chromosomal instability, mitotic dysfunction and cell death. Mutat Res 600(1-2):58-66.
94. Decordier I, Papine A, Plas G, Roesems S, Vande Loock K, Moreno-Palomo J, Cemeli E, Anderson D, Fucic A, Marcos R and others (2009). Automated image analysis of cytokinesis-blocked micronuclei: an adapted protocol and a validated scoring procedure for biomonitoring. Mutagenesis 24(1):85-93.
95. Fenech M and Rinaldi J (1994). The relationship between micronuclei in human lymphocytes and plasma levels of vitamin C, vitamin E, vitamin B12 and folic acid. Carcinogenesis 15(7):1405-11.
96. Gaziev AI, Sologub GR, Fomenko LA, Zaichkina SI, Kosyakova NI and Bradbury RJ (1996). Effect of vitamin-antioxidant micro-nutrients on the frequency of spontaneous and in vitro {gamma}-ray-induced micronu-clei in lymphocytes of donors: the age factor. Carcinogenesis 17(3):493-499. (Pubitemid 26085329)
97. Fenech M (1998). Important variables that influence base-line micronucleus frequency in cytokinesis-blocked lymphocytes-a biomarker for DNA damage in human populations. Mutat Res 404(1-2):155-65. (Pubitemid 29038599)
98. Fenech M (1998). Chromosomal damage rate, aging, and diet. Ann N Y Acad Sci 854:23-36. (Pubitemid 29022790)
99. Bolognesi C, Lando C, Forni A, Landini E, Scarpato R, Migliore L and Bonassi S (1999). Chromosomal damage and ageing: effect on micronuclei frequency in peripheral blood lymphocytes. Age Ageing 28(4):393-7. (Pubitemid 29346836)
100. Bonassi S, Fenech M, Lando C, Lin YP, Ceppi M, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Ban S and others (2001). HUman MicroNucleus project: international database comparison for results with the cytokinesis-block micronucleus assay in human lymphocytes: I. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronu-clei. Environ Mol Mutagen 37(1):31-45.
101. Neri M, Ceppi M, Knudsen LE, Merlo DF, Barale R, Puntoni R and Bonassi S (2005). Baseline micronuclei frequency in children: estimates from meta-and pooled analyses. Environ Health Perspect 113(9):1226-9. (Pubitemid 41387664)
102. Kirsch-Volders M, Mateuca RA, Roelants M, Tremp A, Zeiger E, Bonassi S, Holland N, Chang WP, Aka PV, Deboeck M and others (2006). The effects of GSTM1 and GSTT1 polymorphisms on micronucleus frequencies in human lymphocytes in vivo. Cancer Epidemiol Biomarkers Prev 15(5):1038-42. (Pubitemid 43823537)
103. Mateuca RA, Roelants M, Iarmarcovai G, Aka PV, Godderis L, Tremp A, Bonassi S, Fenech M, Berge-Lefranc JL and Kirsch-Volders M (2008). hOGG1(326), XRCC1(399) and XRCC3(241) polymorphisms influence micronucleus frequencies in human lymphocytes in vivo. Mutagenesis 23(1):35-41. (Pubitemid 351161350)
104. Sari-Minodier I, Orsiere T, Auquier P, Martin F and Botta A (2007). Cytogenetic monitoring by use of the micronucleus assay among hospital workers exposed to low doses of ionizing radiation. Mutat Res 629(2):111-21. (Pubitemid 46603084)
105. Fenech M and Rinaldi J (1995). A comparison of lymphocyte micronuclei and plasma micronutrients in vegetarians and non-vegetarians. Carcinogenesis 16(2):223-30.
106. Fenech MF, Dreosti IE and Rinaldi JR (1997). Folate, vitamin B12, homocysteine status and chromosome damage rate in lymphocytes of older men. Carcinogenesis 18(7):1329-36. (Pubitemid 28134705)
107. Fenech M, Dreosti I and Aitken C (1997). Vitamin-E supplements and their effect on vitamin-E status in blood and genetic damage rate in peripheral blood lymphocytes. Carcinogenesis 18(2):359-64. (Pubitemid 28132429)
108. Fenech M, Aitken C and Rinaldi J (1998). Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults. Carcinogenesis 19(7):1163-71. (Pubitemid 28375365)
109. Odagiri Y and Uchida H. (1998). Influence of serum micronutrients on the incidence of kinetochore-positive or-negative micronuclei in human peripheral blood lymphocytes. Mutat Res 415(1-2):35-45. (Pubitemid 28377244)
110. Bonassi S, Neri M, Lando C, Ceppi M, Lin YP, Chang WP, Holland N, Kirsch-Volders M, Zeiger E and Fenech M (2003). Effect of smoking habit on the frequency of micronu-clei in human lymphocytes: results from the Human MicroNucleus project. Mutat Res 543(2):155-66. (Pubitemid 36324355)
111. Iarmarcovai G, Sari-Minodier I, Orsiere T, De Meo M, Gallice P, Bideau C, Iniesta D, Pompili J, Berge-Lefranc JL and Botta A (2006). A combined analysis of XRCC1, XRCC3, GSTM1 and GSTT1 polymorphisms and centromere content of micro-nuclei in welders. Mutagenesis 21(2): 159-65.
112. Ishikawa H, Yamamoto H, Tian Y, Kawano M, Yamauchi T and Yokoyama K (2004). Evidence of association of the CYP2E1 genetic polymorphism with micronuclei frequency in human peripheral blood. Mutat Res 546(1-2):45-53. (Pubitemid 38130218)
113. Scarpato R, Migliore L, Hirvonen A, Falck G and Norppa H (1996). Cytogenetic monitoring of occupational exposure to pesticides: characterization of GSTM1, GSTT1, and NAT2 genotypes. Environ Mol Mutagen 27(4):263-9. (Pubitemid 26233412)
114. Crott JW, Mashiyama ST, Ames BN and Fenech M (2001). The effect of folic acid deficiency and MTHFR C677T polymorphism on chromosome damage in human lymphocytes in vitro. Cancer Epidemiol Biomarkers Prev 10(10):1089-96. (Pubitemid 32959157)
115. Aka P, Mateuca R, Buchet JP, Thierens H and Kirsch-Volders M (2004). Are genetic polymorphisms in OGG1, XRCC1 and XRCC3 genes predictive for the DNA strand break repair phenotype and genotoxicity in workers exposed to low dose ionising radiations? Mutat Res 556(1-2):169-81. (Pubitemid 39371190)
116. Mateuca R, Aka PV, De Boeck M, Hauspie R, Kirsch-Volders M and Lison D (2005). Influence of hOGG1, XRCC1 and XRCC3 genotypes on biomarkers of genotoxicity in workers exposed to cobalt or hard metal dusts. Toxicol Lett 156(2):277-88. (Pubitemid 40292801)
117. Angelini S, Kumar R, Carbone F, Maffei F, Forti GC, Violante FS, Lodi V, Curti S, Hemminki K and Hrelia P (2005). Micronuclei in humans induced by exposure to low level of ionizing radiation: influence of polymorphisms in DNA repair genes. Mutat Res 570(1):105-17. (Pubitemid 40179273)
118. Iarmarcovai G, Sari-Minodier I, Chaspoul F, Botta C, De Meo M, Orsiere T, Berge-Lefranc JL, Gallice P and Botta A (2005). Risk assessment of welders using analysis of eight metals by ICP-MS in blood and urine and DNA damage evaluation by the comet and micro-nucleus assays; influence of XRCC1 and XRCC3 polymorphisms. Mutagenesis 20(6):425-32. (Pubitemid 41816529)
119. Rzeszowska-Wolny J, Polanska J, Pietrowska M, Palyvoda O, Jaworska J, Butkiewicz D and Hancock R (2005). Influence of polymorphisms in DNA repair genes XPD, XRCC1 and MGMT on DNA damage induced by gamma radiation and its repair in lymphocytes in vitro. Radiat Res 164(2):132-40. (Pubitemid 41045593)
120. Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Ban S, Barale R and others (2007). An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 28(3):625-31. (Pubitemid 46523357)
121. Murgia E, Ballardin M, Bonassi S, Rossi AM and Barale R (2008). Validation of micronu-clei frequency in peripheral blood lymphocytes as early cancer risk biomarker in a nested case-control study. Mutat Res 639(1-2):27-34.
122. Iarmarcovai G, Ceppi M, Botta A, Orsiere T and Bonassi S (2008). Micronuclei frequency in peripheral blood lymphocytes of cancer patients: a meta-analysis. Mutat Res 659(3):274-83.
123. El-Zein RA, Schabath MB, Etzel CJ, Lopez MS, Franklin JD and Spitz MR (2006). Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res 66(12):6449-56.
124. Dudarewicz L, Holzgreve W, Jeziorowska A, Jakubowski L and Zimmermann B (2005). Molecular methods for rapid detection of aneuploidy. J Appl Genet 46(2):207-15. (Pubitemid 40840276)
125. Schrock E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D and others (1996). Multicolor spectral karyotyping of human chromosomes. Science 273(5274):494-7. (Pubitemid 26286449)
126. Speicher MR and Ward DC (1996). The coloring of cytogenetics. Nature Med 2(9):1046-8. (Pubitemid 27372311)
127. Horstmann M and Obe G (2003). CABAND: Classification of aberrations in
128. Chudoba I, Hickmann G, Friedrich T, Jauch A, Kozlowski P and Senger G (2004). mBAND: a high resolution multicolor banding technique for the detection of complex intrachromosomal aberrations. Cytogenet Genome Res 104(1-4):390-3. (Pubitemid 38721108)
129. Elhajouji A, Van Hummelen P and Kirsch-Volders M (1995). Indications for a threshold of chemically-induced aneuploidy in vitro in human lymphocytes. Environ Mol Mutagen 26(4):292-304. (Pubitemid 26035493)
130. Elhajouji A, Tibaldi F and Kirsch-Volders M (1997). Indication for thresholds of chromosome non-disjunction versus chromosome lagging induced by spindle inhibitors in vitro in human lymphocytes. Mutagenesis 12(3):133-40. (Pubitemid 27234648)
131. Godderis L, De Boeck M, Haufroid V, Emmery M, Mateuca R, Gardinal S, Kirsch-Volders M, Veulemans H and Lison D (2004). Influence of genetic polymorphisms on bio-markers of exposure and genotoxic effects in styrene-exposed workers. Environ Mol Mutagen 44(4):293-303. (Pubitemid 39447233)
132. Skjelbred CF, Svendsen M, Haugan V, Eek AK, Clausen KO, Svendsen MV and Hansteen IL (2006). Influence of DNA repair gene polymorphisms of hOGG1, XRCC1, XRCC3, ERCC2 and the folate metabolism gene MTHFR on chromosomal aberration frequencies. Mutat Res 602(1-2):151-62. (Pubitemid 44693567)
133. McCanlies E, Landsittel DP, Yucesoy B, Vallyathan V, Luster ML and Sharp DS (2002). Significance of genetic information in risk assessment and individual classification using silicosis as a case model. Ann Occup Hyg 46(4):375-81. (Pubitemid 36554319)